Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,694.4 | 94.92 | 4,06,519.32 | 2,000.46 | 0.94 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,633 | 79.63 | 1,75,903.46 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,506.6 | 24.7 | 1,21,666.43 | 1,485.4 | 1.06 | 4,254.47 | 397.42 |
Dr Reddys Laboratories Ltd DRREDDY | 1,319.1 | 20.58 | 1,10,089.7 | 1,200.7 | 0.61 | 5,546.3 | 345.81 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,180.7 | 56.47 | 1,07,600.51 | 474 | 1.01 | 2,385 | 224.33 |
Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
